{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"150","value":"50"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"description":"Blood lost during procedure","dispersionType":"Full Range","groups":[{"description":"Pilot study; single arm - use of da Vinci Surgical Robot Platform to access neoplastic disease of the upper aerodigestive tract.\n\nda Vinci Surgical Robot Platform: daVinci Surgical Robot Platform is a surgical device that enhances transoral access to the upper aerodigestive tract through miniaturization of endoscopes and micromanipulators that can be introduced through the mouth.\n\nTransoral Robotic Surgery: Eligible patients will undergo transoral treatment of neoplastic disease of the upper aerodigestive tract using the daVinci Surgical Robot Platform as opposed to traditional (TOL - transoral laser; TEC - transoral electrocautery) methods.","id":"OG000","title":"Transoral Robotic Surgery"}],"paramType":"MEAN","populationDescription":"Participants","reportingStatus":"POSTED","timeFrame":"Duration of procedure up to two hours","title":"Average Blood Loss","type":"SECONDARY","unitOfMeasure":"mL"}